BaseSpace
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Early pregnancy factor, Rapamycin, rs6983267, IGF1, Metabolism of xenobiotics)
Bookmark Forward

QuickView for PIM1 (gene)


Body Atlas

Most Correlated Tissues

  1. Basophil of peripheral blood
  2. Oral mucosa
  3. T Lymphocyte (regulatory) of peripheral blood
  4. T Lymphocyte (CD4+) of peripheral blood
  5. Pharyngeal mucosa
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Pyloric ulcer
  2. Toxoplasmosis
  3. Ischemia
  4. Drug resistance
  5. Behavior finding
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. marimastat
  2. 2-methylthio-ATP
  3. N-(4-(3-amino-1H-indazol-4-yl)phenyl)-N1-(2-fluoro-5-methylphenyl)urea
  4. 1,2,4,5-benzenetetraamine tetrahydrochloride
  5. Interleukin-3
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. NET1
  2. GNB1
  3. AGER
  4. NSFL1C
  5. FGFR1
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Loading...
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Regulation of Erythroid Differentiation via the HIF1α-NFIL3-PIM1 Signaling Axis Under Hypoxia.
  2. Discovery of 5-Azaindazole (GNE-955) as a Potent Pan-Pim Inhibitor with Optimized Bioavailability.
  3. Discovery of N-substituted 7-azaindoles as Pan-PIM kinase inhibitors - Lead series identification - …
  4. Targeting Pim kinases for cancer treatment: opportunities and challenges.
  5. The discovery of novel 3-(pyrazin-2-yl)-1H-indazoles as potent pan-Pim kinase inhibitors.
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. A Study of Abemaciclib in Combination With Sunitinib in Metastatic Renal Cell Carcinoma
  2. Evaluating Omitting of Internal Mammary Irradiation Among Early Stage Intermediate Risk (N1) Breast …
  3. Ibrutinib Combined With Rituximab for Treatment of Relapsed Refractory MYD88 and CD79A/B (or CD79B A…
  4. Pediatric Integrative Medicine Trial Pilot
  5. Identification Predictive Markers of Immunochemotherapy Response to the Primary Cutaneous Diffuse La…
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.